# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 496 results.
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B
Status: Recruiting
Last Changed: Feb 12, 2018
First Received: Feb 12, 2018
Disease(s): Chronic Hepatitis b
Intervention(s): intestinal microbiota transplant, Antiviral Agents
Locations: Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian, China
Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Status: Recruiting
Last Changed: Nov 13, 2019
First Received: Feb 19, 2014
Disease(s): Chronic Hepatitis C Infection
Locations: St Vincent's Hospital, Sydney, New South Wales, Australia
St Vincent's Hospital, Melbourne, Victoria, Australia
Study of the Clinical Features of Autoimmune Hepatitis
Status: Recruiting
Last Changed: Sep 12, 2019
First Received: Dec 16, 2016
Disease(s): Hepatitis, Autoimmune
Intervention(s): Different biochemical results or pathogenesis.
Locations: Division of Gastroenterology & Hepatology,West China Hospital,Sichuan University, Chengdu, Sichuan, China
Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population
Status: Not yet recruiting
Last Changed: May 24, 2019
First Received: May 24, 2019
Disease(s): Hepatitis B Vaccine
Intervention(s): 20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6
Locations: The Central Hospital of Linfen, Linfen, China
The People's Hospital of Linfen, Linfen, China
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
Status: Recruiting
Last Changed: Sep 02, 2020
First Received: Dec 17, 2015
Disease(s): Hepatitis C, Acute
Intervention(s): Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin, Glecaprevir/pibrentasvir
Locations: St Vincent's Hospital, Sydney, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Alfred Hospital, Melbourne, Victoria, Australia
Auckland City Hospital, Auckland, Grafton, New Zealand
Christchurch Hospital, Christchurch, New Zealand
... and 7 other locations.
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)
Status: Recruiting
Last Changed: Sep 28, 2018
First Received: Sep 21, 2018
Disease(s): Non Small Cell Lung Cancer, Hepatitis B
Intervention(s): Entecavir 1Mg Oral Tablet
Locations: Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Status: Recruiting
Last Changed: Nov 18, 2019
First Received: Sep 12, 2019
Disease(s): Alcoholic Hepatitis
Intervention(s): Blood Draw
Locations: Cleveland Clinic Foundation, Cleveland, Ohio, United States
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Status: Not yet recruiting
Last Changed: Mar 10, 2020
First Received: Mar 10, 2020
Disease(s): Chronic Hepatitis b
Intervention(s): interferon
Locations: Department of Hepatology Division 2, Beijing Ditan Hospital, Beijing, Beijing, China
Oral Microbiome of Patients With Hepatitis C Virus Infection
Status: Not yet recruiting
Last Changed: Apr 24, 2020
First Received: Sep 24, 2018
Disease(s): Hepatitis C Viral
Intervention(s): Oral microbiome analysis
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
Status: Recruiting
Last Changed: Sep 16, 2020
First Received: Nov 30, 2018
Disease(s): Hepatitis B, Chronic
Intervention(s): Ribavirin, Tenofovir
Locations: Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada